Remedy Robotics is a leading healthcare and physical AI company developing AI-enabled endovascular robotic systems and software for on-premise, remote, and autonomous intervention. Its proprietary N1 System combines robotics, AI, and advanced computer vision to raise the standard of care across the cardiovascular continuum-from diagnosis and intervention to discharge and surveillance-bringing expert-level treatment within reach of patients wherever they are. The company holds 48 patents covering its platform, including foundational patents in machine learning applied to surgical robotics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/16/26 | $62,000,000 | Series B |
Blackbird Ventures Build Collective DCVC ![]() Divergent Capital Hostplus KdT Ventures Skip Capital UC Investments | undisclosed |